University of California San Diego Moores Cancer Center (UCSD)
Welcome,         Profile    Billing    Logout  
 6 Trials 
10 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Kesari, Santosh
NCT02833792: Allogeneic Human Mesenchymal Stem Cells for Alzheimer's Disease

Recruiting
2a
40
US
Human Mesenchymal Stem Cells and Lactated Riunger's Solution, Placebo
Stemedica Cell Technologies, Inc., Stemedica International SA
Alzheimer Dementia
07/24
12/24
NCT04780685: A Phase II Study in Patients With Moderate to Severe ARDS Due to COVID-19

Recruiting
2
40
US
hMSC, allogeneic mesenchymal bone marrow cells
Stemedica Cell Technologies, Inc., bioRASI, LLC
Covid19
09/22
12/22
NCT02847559: Optune Delivered Electric Field Therapy and Bevacizumab in Treating Patients With Recurrent or Progressive Grade 2 or 3 Meningioma

Recruiting
2
27
US
Bevacizumab, Anti-VEGF, Anti-VEGF Humanized Monoclonal Antibody, Anti-VEGF rhuMAb, Avastin, Bevacizumab Biosimilar BEVZ92, Bevacizumab Biosimilar BI 695502, Immunoglobulin G1 (Human-Mouse Monoclonal rhuMab-VEGF Gamma-Chain Anti-Human Vascular Endothelial Growth Factor), Disulfide With Human-Mouse Monoclonal rhuMab-VEGF Light Chain, Dimer, Recombinant Humanized Anti-VEGF Monoclonal Antibody, rhuMab-VEGF, Electric Field Therapy, NovoTTF-200A Device, NovoTTF-200A, NovoTTF-200A System, NovoTTFields, NovoTumor Treatment Fields, Optune, Optune Device, Quality-of-Life Assessment, Quality of Life Assessment
Northwestern University, NovoCure Ltd., National Cancer Institute (NCI)
Anaplastic (Malignant) Meningioma, Atypical Meningioma, Grade II Meningioma, Grade III Meningioma, Recurrent Meningioma, Supratentorial Meningioma
09/26
12/26
NCT04762069 / 2021-003659-40: A Study of Berubicin in Adult Subjects With Recurrent Glioblastoma Multiforme

Hourglass Jan 2023 - Jun 2023 : Data from trial for glioblastoma
Hourglass Jul 2022 - Dec 2022 : Interim analysis data from trial for glioblastoma in adults
Active, not recruiting
2
210
Europe, US
Berubicin, Berubicin Hydrochloride, Lomustine, Lomustine Capsules, CCNU, CeeNU, Gleostine
CNS Pharmaceuticals, Inc., Worldwide Clinical Trials
Glioblastoma Multiforme, Adult
12/24
03/25
IORT, NCT04681677: Recurrent GBM Treated With Neurosurgical Resection and Using the Xoft Axxent eBx System and Bevacizumab

Terminated
2
12
US
Radiation: Intra-operative Radiation Therapy - IORT, Bevacizumab, Avastin
Xoft, Inc., Icad, Inc.
Glioblastoma, Recurrent Glioblastoma, GBM, Recurrent GBM
04/24
04/24
DIET2TREAT, NCT05708352: A Phase 2 Study of the Ketogenic Diet Vs Standard Anti-cancer Diet Guidance for Patients with Glioblastoma in Combination with Standard-of-care Treatment

Recruiting
2
170
US
Keto Diet, Standard Anti-Cancer Diet
Cedars-Sinai Medical Center, National Cancer Institute (NCI)
Glioblastoma Multiforme
06/28
06/29
NCT03955042: Pemetrexed for the Treatment of Chordoma

Completed
1
15
US
Pemetrexed, Alimta
Saint John's Cancer Institute, Eli Lilly and Company, Chordoma Foundation
Chordoma
07/22
01/23
NCT03425292: A Longitudinal Assessment of Tumor Evolution in Patients With Brain Cancer

Completed
1
49
US
Temozolomide, temodar, conformal brain radiation therapy, Nivolumab, opdivo, Ipilimumab, yervoy, Bevacizumab, avastin, 5-day Temozolomide, Lomustine, CCNU, Nivolumab monotherapy
Saint John's Cancer Institute
Newly Diagnosed High Grade Glioma
09/22
10/23
NCT05561374: Study of Safety and Pharmacokinetic Properties of Oral OKN-007 in Patients with Recurrent High-Grade Glioma

Active, not recruiting
1
16
US
Low-dose OKN-007, BID, Low-dose OKN-007, TID, Mid-dose OKN-007, TID, High-dose OKN-007, TID
Oblato, Inc.
High-grade Glioma, Oligodendroglioma, Astrocytoma, Glioblastoma Multiforme
05/25
06/25
NCT06404034: Expanded Access to Gallium Maltolate (GaM)

Available
N/A
US
Gallium Maltolate, GaM
Imaging Biometrics, LLC, xCures
Glioblastoma, Refractory Glioblastoma, Glioblastoma Multiforme
 
 
Nguyen, Angel
No trials found

Download Options